Trade AstraZeneca PLC - GBP - AZNl CFD
Add to favourite- Summary
- Historical Data
| Spread | 2.42 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023252% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001334% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | GBP | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 113.88 |
| Open | 115.8 |
| 1-Year Change | 13.19% |
| Day's Range | 114.76 - 117.06 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 114.76 | -0.26 | -0.23% | 115.02 | 117.12 | 113.36 |
| Feb 20, 2025 | 113.88 | -0.68 | -0.59% | 114.56 | 115.96 | 113.88 |
| Feb 19, 2025 | 115.74 | -1.88 | -1.60% | 117.62 | 118.24 | 114.58 |
| Feb 18, 2025 | 117.60 | 0.38 | 0.32% | 117.22 | 118.30 | 116.76 |
| Feb 17, 2025 | 115.02 | 0.40 | 0.35% | 114.62 | 117.20 | 114.32 |
| Feb 14, 2025 | 116.96 | -1.24 | -1.05% | 118.20 | 118.86 | 116.10 |
| Feb 13, 2025 | 117.88 | -2.01 | -1.68% | 119.89 | 120.41 | 117.46 |
| Feb 12, 2025 | 118.12 | 1.92 | 1.65% | 116.20 | 118.20 | 113.98 |
| Feb 11, 2025 | 114.16 | -2.56 | -2.19% | 116.72 | 116.90 | 114.16 |
| Feb 10, 2025 | 114.94 | -0.26 | -0.23% | 115.20 | 117.86 | 114.94 |
| Feb 7, 2025 | 115.78 | 0.28 | 0.24% | 115.50 | 116.68 | 114.66 |
| Feb 6, 2025 | 117.14 | 3.66 | 3.23% | 113.48 | 119.62 | 111.84 |
| Feb 5, 2025 | 111.26 | 1.10 | 1.00% | 110.16 | 111.46 | 108.25 |
| Feb 4, 2025 | 110.46 | -1.06 | -0.95% | 111.52 | 112.90 | 109.51 |
| Feb 3, 2025 | 112.48 | 0.82 | 0.73% | 111.66 | 113.36 | 111.66 |
| Jan 31, 2025 | 113.74 | 0.06 | 0.05% | 113.68 | 113.96 | 113.00 |
| Jan 30, 2025 | 113.00 | 0.80 | 0.71% | 112.20 | 113.18 | 110.28 |
| Jan 29, 2025 | 110.16 | -0.92 | -0.83% | 111.08 | 113.14 | 110.16 |
| Jan 28, 2025 | 110.14 | -1.68 | -1.50% | 111.82 | 112.72 | 110.14 |
| Jan 27, 2025 | 111.88 | 1.40 | 1.27% | 110.48 | 112.00 | 110.12 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - GBP Company profile
About AstraZeneca plc
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
| Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com